Analysts Set Dyne Therapeutics, Inc. (NASDAQ:DYN) Price Target at $43.93
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Moderate Buy” from the sixteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy […]
Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) have earned an average rating of “Moderate Buy” from the sixteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has assigned a strong buy […]
